Crescendo Health is a technology company.
Crescendo Health has raised $3.0M across 1 funding round.
Crescendo Health has raised $3.0M in total across 1 funding round.
Crescendo Health is a digital health technology company that builds a secure, cloud-based platform enabling patients participating in clinical research to aggregate and share their longitudinal health data with researchers. The platform serves biopharma companies, medical device manufacturers, contract research organizations, and healthcare researchers by unlocking traditionally siloed patient health information from multiple healthcare providers. This comprehensive real-world data helps clinical research sponsors better understand long-term health outcomes, improve trial efficiency, and reduce costs. Crescendo’s model also benefits patients by giving them access to their own curated medical records collected during clinical studies, enhancing transparency and engagement[1][3][4].
Founded by Sam Roosz, co-founder of Datavant (which merged with Ciox in a $7 billion deal), and Michael Glassman, a former product leader at Grand Rounds, Crescendo Health emerged from their shared vision to improve medical research through better data access and patient empowerment. The company officially launched after successful pilot studies with top clinical research organizations, backed by $3.4 million in initial funding led by Define Ventures and other prominent investors. The founders leveraged their deep experience in healthcare data and digital health to create a public benefit corporation focused on societal impact and advancing clinical trials through innovative data technology[1][4][5].
Crescendo Health rides the growing trend of real-world evidence (RWE) and decentralized clinical trials, which aim to make medical research more patient-centric, efficient, and reflective of actual patient experiences outside controlled trial settings. The timing is favorable due to regulatory changes increasing patient data access and the healthcare industry's push for data-driven decision-making. By enabling seamless, secure data sharing between patients and researchers, Crescendo addresses fragmentation in healthcare data and supports the shift toward value-based care and personalized medicine. Their platform helps accelerate therapeutic development and post-market safety monitoring, influencing the broader ecosystem by setting new standards for data interoperability and patient engagement in clinical research[1][3][5].
Looking ahead, Crescendo Health is positioned to expand its impact by scaling partnerships with life science organizations and broadening the use cases for real-world data in clinical trials and postmarketing studies. Trends such as increased regulatory emphasis on data transparency, advances in health IT interoperability, and growing patient demand for control over personal health information will shape their journey. As the company matures, it may further influence the clinical research landscape by enabling more decentralized, inclusive, and cost-effective trials, ultimately accelerating the development of new treatments and improving patient outcomes globally. Crescendo’s public benefit mission and innovative technology platform make it a key player in transforming how health data drives medical innovation[1][3][4][5].
Crescendo Health has raised $3.0M in total across 1 funding round.
Crescendo Health's investors include Alliance Healthcare Foundation, Define Ventures, Rising Tide Partners, Vertical Venture Partners.
Crescendo Health has raised $3.0M across 1 funding round. Most recently, it raised $3.0M Seed in January 2023.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jan 1, 2023 | $3.0M Seed | Alliance Healthcare Foundation, Define Ventures, Rising Tide Partners, Vertical Venture Partners |